Successful trial of dengue vaccine conducted in Bangladesh

Successful trial of dengue vaccine conducted in Bangladesh

ICDDR,B, and the Larner College of Medicine at the University of Vermont (UVM), jointly conducted trial of dengue vaccine for the first time in Bangladesh.
ICDDR,B, and the Larner College of Medicine at the University of Vermont (UVM), are the first to study a promising tetravalent dengue vaccine in dengue-endemic Bangladesh, said a press release today.
Their work, evaluating the single-dose tetravalent dengue vaccine candidate TV005, demonstrated safety and immune responsiveness in children and adults, it said adding the accompanying study was recently published in the journal The Lancet Infectious Diseases.